GENEROUS Promises Lower Medicaid Drug Prices—But Who Benefits?

All 50 state Medicaid programs have applied to the federal GENEROUS drug-pricing model, which would use additional manufacturer rebates tied to selected international prices. The applications are not yet final, and the model’s savings, drug coverage, and effect on patients remain uncertain.

Read the full discussion and sources:

https://factolio.com/?p=2904